Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors
Akira Yuno(National Institutes of Health), Jane B. Trepel(National Institutes of Health), Yusuke Tomita(Kumamoto University Hospital), Min-Jung Lee(Center for Cancer Research), David Rekhtman(Center for Cancer Research), Brittni N. Moore(Johns Hopkins University), Sunmin Lee(National Institutes of Health)
Cited by 122
Related Papers
Targeting the dynamic HSP90 complex in cancer
|Nature reviews. Cancer|2010|1.5k
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|Journal for ImmunoTherapy of Cancer|2018|312
Destabilization of Raf-1 by Geldanamycin Leads to Disruption of the Raf-1–MEK–Mitogen-Activated Protein Kinase Signalling Pathway
|Molecular and Cellular Biology|1996|275
Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021
|Hypertension|2022|91
Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation
|Clinical Cancer Research|2019|61